229 related articles for article (PubMed ID: 33340175)
1. Alveolar progenitor cells and the origin of lung cancer.
Sainz de Aja J; Dost AFM; Kim CF
J Intern Med; 2021 May; 289(5):629-635. PubMed ID: 33340175
[TBL] [Abstract][Full Text] [Related]
2. Alveolar type I cells can give rise to KRAS-induced lung adenocarcinoma.
Yang M; Shen H; Flodby P; Koss MD; Bassiouni R; Liu Y; Jashashvili T; Neely A; Ogbolu E; Castillo J; Stueve TR; Mullen DJ; Ryan AL; Carpten J; Castaldi A; Wallace WD; Zhou B; Borok Z; Marconett CN
Cell Rep; 2023 Dec; 42(12):113286. PubMed ID: 37995179
[TBL] [Abstract][Full Text] [Related]
3. KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming.
Juul NH; Yoon JK; Martinez MC; Rishi N; Kazadaeva YI; Morri M; Neff NF; Trope WL; Shrager JB; Sinha R; Desai TJ
Nature; 2023 Jul; 619(7971):860-867. PubMed ID: 37468622
[TBL] [Abstract][Full Text] [Related]
4. Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma.
Li Z; Zhuang X; Pan CH; Yan Y; Thummalapalli R; Hallin J; Torborg S; Singhal A; Chang JC; Manchado E; Dow LE; Yaeger R; Christensen JG; Lowe SW; Rudin CM; Joost S; Tammela T
Cancer Discov; 2024 Feb; 14(2):308-325. PubMed ID: 37931288
[TBL] [Abstract][Full Text] [Related]
5. Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform.
Naranjo S; Cabana CM; LaFave LM; Romero R; Shanahan SL; Bhutkar A; Westcott PMK; Schenkel JM; Ghosh A; Liao LZ; Del Priore I; Yang D; Jacks T
Genes Dev; 2022 Aug; 36(15-16):936-949. PubMed ID: 36175034
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation.
Regala RP; Justilien V; Walsh MP; Weems C; Khoor A; Murray NR; Fields AP
PLoS One; 2011; 6(10):e26439. PubMed ID: 22022614
[TBL] [Abstract][Full Text] [Related]
7. Tumor progression and chromatin landscape of lung cancer are regulated by the lineage factor GATA6.
Arnal-Estapé A; Cai WL; Albert AE; Zhao M; Stevens LE; López-Giráldez F; Patel KD; Tyagi S; Schmitt EM; Westbrook TF; Nguyen DX
Oncogene; 2020 Apr; 39(18):3726-3737. PubMed ID: 32157212
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.
Nokin MJ; Darbo E; Travert C; Drogat B; Lacouture A; San José S; Cabrera N; Turcq B; Prouzet-Mauleon V; Falcone M; Villanueva A; Wang H; Herfs M; Mosteiro M; Jänne PA; Pujol JL; Maraver A; Barbacid M; Nadal E; Santamaría D; Ambrogio C
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759499
[TBL] [Abstract][Full Text] [Related]
9. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma.
Xu X; Rock JR; Lu Y; Futtner C; Schwab B; Guinney J; Hogan BL; Onaitis MW
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4910-5. PubMed ID: 22411819
[TBL] [Abstract][Full Text] [Related]
10. YTHDF1 Promotes Cyclin B1 Translation through m
Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W
Cells; 2021 Jul; 10(7):. PubMed ID: 34359836
[TBL] [Abstract][Full Text] [Related]
11. Club cells employ regeneration mechanisms during lung tumorigenesis.
Chen Y; Toth R; Chocarro S; Weichenhan D; Hey J; Lutsik P; Sawall S; Stathopoulos GT; Plass C; Sotillo R
Nat Commun; 2022 Aug; 13(1):4557. PubMed ID: 35931677
[TBL] [Abstract][Full Text] [Related]
12. Alveolar progenitor and stem cells in lung development, renewal and cancer.
Desai TJ; Brownfield DG; Krasnow MA
Nature; 2014 Mar; 507(7491):190-4. PubMed ID: 24499815
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor of Differentiation-1 Sustains Mutant
Román M; López I; Guruceaga E; Baraibar I; Ecay M; Collantes M; Nadal E; Vallejo A; Cadenas S; Miguel ME; Jang JH; Martin-Uriz PS; Castro-Labrador L; Vilas-Zornoza A; Lara-Astiaso D; Ponz-Sarvise M; Rolfo C; Santos ES; Raez LE; Taverna S; Behrens C; Weder W; Wistuba II; Vicent S; Gil-Bazo I
Cancer Res; 2019 Feb; 79(3):625-638. PubMed ID: 30563891
[TBL] [Abstract][Full Text] [Related]
14. Identification of Sca-1
Yin H; Jiang Z; Feng X; Ji Z; Jin W
Oncogene; 2020 Apr; 39(18):3754-3773. PubMed ID: 32157214
[TBL] [Abstract][Full Text] [Related]
15. Cell-type specific tumorigenesis with Ras oncogenes in human lung epithelial cells.
Kumazaki M; Shimomura I; Kiyono T; Ochiya T; Yamamoto Y
Biochem Biophys Res Commun; 2020 Apr; 525(2):483-490. PubMed ID: 32111352
[TBL] [Abstract][Full Text] [Related]
16. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
Zhu HE; Yin JY; Chen DX; He S; Chen H
Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
[TBL] [Abstract][Full Text] [Related]
17. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
18. Modeling K-Ras-driven lung adenocarcinoma in mice: preclinical validation of therapeutic targets.
Drosten M; Barbacid M
J Mol Med (Berl); 2016 Feb; 94(2):121-35. PubMed ID: 26526121
[TBL] [Abstract][Full Text] [Related]
19. Alveolar type II cells possess the capability of initiating lung tumor development.
Lin C; Song H; Huang C; Yao E; Gacayan R; Xu SM; Chuang PT
PLoS One; 2012; 7(12):e53817. PubMed ID: 23285300
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor Etv5 is essential for the maintenance of alveolar type II cells.
Zhang Z; Newton K; Kummerfeld SK; Webster J; Kirkpatrick DS; Phu L; Eastham-Anderson J; Liu J; Lee WP; Wu J; Li H; Junttila MR; Dixit VM
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3903-3908. PubMed ID: 28351980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]